Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Forecast calculations
1.4 Data sources
1.4.1 Primary
1.4.2 Secondary
1.4.2.1 Paid sources
1.4.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Thrombectomy devices industry 360° synopsis, 2018 - 2032
2.2 Business trends
2.3 Regional trends
2.4 Product type trends
2.5 Application trends
2.6 End-use trends
Chapter 3 Thrombectomy Devices Industry Insights
3.1 Impact on COVID-19
3.2 Industry ecosystem analysis
3.3 Technology landscape
3.4 Regulatory landscape
3.5 Industry impact forces
3.5.1 Growth drivers
3.5.1.1 Increasing prevalence of cardiovascular disorders
3.5.1.2 Technological advancements in thrombectomy devices
3.5.1.3 Increasing adoption of minimally invasive procedures
3.5.1.4 Growing number of healthcare facilities and skilled professionals in emerging countries
3.5.2 Industry pitfalls & challenges
3.5.2.1 Stringent regulatory scenario
3.5.2.2 Lack of awareness regarding peripheral artery diseases
3.6 Growth potential analysis
3.6.1 By product type
3.6.2 By applicaion
3.6.3 By end-use
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.1.1 Johnson & Johnson Services Inc.
4.1.2 Medtronic, Plc.
4.1.3 Boston Scientific Corporation
4.1.4 Stryker Corporation
4.2 Company market share, 2022
4.3 Competitive analysis of major market players, 2022
4.4 Competitive positioning matrix, 2022
4.5 Strategic outlook matrix, 2022
Chapter 5 Thrombectomy Devices Market Estimates and Forecast, By Product Type (Revenue)
5.1 Key trends, by product type
5.2 Ultrasound-assisted thrombectomy devices
5.3 Rotational thrombectomy devices
5.4 Aspiration thrombectomy devices
5.5 Mechanical/fragmentation thrombectomy devices
5.6 Clot extraction catheter
5.7 Stent retrievers
5.8 Microcatheters
5.9 Others
Chapter 6 Thrombectomy Devices Market Estimates and Forecast, By Application (Revenue)
6.1 Key trends, by application
6.2 Peripheral thrombectomy
6.3 Neurovascular thrombectomy
6.4 Cardiovascular thrombectomy
Chapter 7 Thrombectomy Devices Market Estimates and Forecast, By End-use (Revenue)
7.1 Key trends, by end-use
7.2 Hospitals
7.3 Ambulatory surgical centers
7.4 Others
Chapter 8 Thrombectomy Devices Market Estimates and Forecast, By Region (Revenue)
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Switzerland
8.3.7 The Netherlands
8.3.8 Denmark
8.3.9 Poland
8.3.10 Sweden
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 New Zealand
8.4.7 Vietnam
8.4.8 Indonesia
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Colombia
8.5.5 Chile
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 South Africa
8.6.3 UAE
8.6.4 Turkey
Chapter 9 Company Profiles
9.1 Weigao group (Argon Medical)
9.2 Boston Scientific Corporation
9.3 Edwards lifesciences Corporation
9.4 Johnson & Johnson Services Inc.
9.5 Lemaitre Vascular Inc.
9.6 Medtronic Plc.
9.7 Penumbra, Inc.
9.8 Stryker Corporation
9.9 Teleflex Incorporated
9.10 Terumo Corporation
